Skip to main content
    E

    Electromed Inc (ELMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $23.16
    -1.16 (-4.77%)

    Market Cap: $198.79M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Electromed Inc (ELMD) Earnings: Report Dates and Results

    Updated Nov 10, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Electromed (ELMD) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Electromed reported EPS of $0.32, above the $0.26 estimate. It beat the EPS estimate in each of the last 12 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    71%(24/34)
    Avg Surprise
    +60.42%
    Streak
    12 Q

    Upcoming Estimates

    Reports Feb 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.39
    Range$0.36 - $0.41
    2 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.39-2.1%
    60d ago$0.39-2.1%
    30d ago$0.39-2.1%
    7d ago$0.39-2.1%
    Current$0.39
    Revenue Consensus
    $21.20M
    Range$21.20M - $21.20M
    1 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.40
    Range$0.39 - $0.41
    2 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.40+0.8%
    60d ago$0.41-1.2%
    30d ago$0.41-1.2%
    7d ago$0.41-1.2%
    Current$0.40
    Revenue Consensus
    $21.00M
    Range$21.00M - $21.00M
    1 analysts

    Next Report

    ELMD has an expected report date of Feb 8, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 21.9% above the $0.32 reported for the quarter ended Dec 31, 2025.

    ELMD Earnings Call

    The latest ELMD earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 34 quarters below that had an estimate, ELMD beat 24, missed 9 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $18.68M, up 10.6% from $16.89M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.32$0.26$0.22 - $0.29+23.08%Beat+28.0%20 up, 1 downNov 10, 2026$18.68M
    Jun 30, 2026$0.39$0.32$0.30 - $0.33+21.88%Beat+56.0%33 up, 0 downAug 25, 2026$19.42M
    Mar 31, 2026$0.35$0.24$0.24 - $0.26+46.23%Beat+65.4%31 up, 1 downMay 12, 2026$18.57M
    Dec 31, 2025$0.32$0.26$0.24 - $0.28+23.08%Beat+45.5%42 up, 2 downFeb 10, 2026$18.90M
    Sep 30, 2025$0.25$0.21$0.19 - $0.23+19.05%Beat+56.3%41 up, 1 downNov 12, 2025$16.89M
    Jun 30, 2025$0.25$0.22$0.21 - $0.22+13.64%Beat+25.0%20 up, 2 downAug 26, 2025$17.39M
    Mar 31, 2025$0.21$0.20N/A+5.00%Beat+23.5%N/A0 up, 0 downMay 13, 2025$15.68M
    Dec 31, 2024$0.22$0.18N/A+22.22%Beat+15.8%N/A0 up, 0 downFeb 11, 2025$16.25M
    Sep 30, 2024$0.16$0.03$0.03 - $0.03+433.33%Beat+700.0%10 up, 0 downNov 12, 2024$14.67M
    Jun 30, 2024$0.20$0.14N/A+42.86%Beat+66.7%N/A0 up, 0 downAug 27, 2024$14.83M
    Mar 31, 2024$0.17$0.13$0.13 - $0.13+30.77%Beat+41.7%10 up, 0 downMay 7, 2024$13.87M
    Dec 31, 2023$0.19$0.10$0.10 - $0.10+90.00%Beat+72.7%10 up, 0 downFeb 13, 2024$13.69M
    Sep 30, 2023$0.02$0.10$0.10 - $0.10-80.00%Miss+100.0%10 up, 0 downNov 7, 2023$12.32M
    Jun 30, 2023$0.12$0.13N/A-7.69%Miss+200.0%N/A0 up, 0 downAug 22, 2023$13.61M
    Mar 31, 2023$0.12$0.10$0.10 - $0.10+20.00%Beat+71.4%10 up, 0 downMay 9, 2023$12.07M
    Dec 31, 2022$0.11$0.02$0.01 - $0.06+450.00%Beat+10.0%20 up, 0 downFeb 14, 2023$11.73M
    Sep 30, 2022$0.01$0.04$0.03 - $0.04-75.00%Miss-80.0%20 up, 0 downNov 8, 2022$10.66M
    Jun 30, 2022$0.04$0.08$0.08 - $0.08-50.00%Miss0.0%10 up, 0 downAug 23, 2022$11.27M
    Mar 31, 2022$0.07$0.05N/A+40.00%Beat+133.3%N/A0 up, 0 downMay 10, 2022$10.14M
    Dec 31, 2021$0.10$0.07$0.07 - $0.07+42.86%Beat-23.1%10 up, 0 downFeb 8, 2022$10.25M
    Sep 30, 2021$0.05$0.06$0.02 - $0.10-16.67%Miss-16.7%21 up, 0 downNov 9, 2021$10.00M
    Jun 30, 2021$0.04$0.06$0.05 - $0.06-33.33%Miss-71.4%2N/AAug 24, 2021$9.47M
    Mar 31, 2021$0.03$0.06N/A-50.00%Miss-57.1%N/AN/AMay 11, 2021$8.79M
    Dec 31, 2020$0.13$0.04$0.01 - $0.07+225.00%Beat-7.1%2N/AFeb 9, 2021$9.50M
    Sep 30, 2020$0.06-$0.05-$0.05 - -$0.05+220.00%Beat-50.0%1N/ANov 10, 2020$8.00M
    Jun 30, 2020$0.14-$0.15-$0.15 - -$0.15+193.33%Beat+7.7%1N/AAug 25, 2020$6.88M
    Mar 31, 2020$0.07$0.06N/A+16.67%Beat+75.0%N/AN/AMay 12, 2020$8.74M
    Dec 31, 2019$0.14$0.04$0.04 - $0.04+250.00%Beat+250.0%1N/AFeb 11, 2020$8.55M
    Sep 30, 2019$0.12$0.01$0.01 - $0.01N/AN/A+500.0%1N/ANov 12, 2019$8.30M
    Jun 30, 2019$0.13$0.13N/A0.00%In line0.0%N/AN/AAug 27, 2019$8.60M
    Mar 31, 2019$0.04N/AN/AN/AN/A0.0%N/AN/AMay 7, 2019$7.41M
    Dec 31, 2018$0.04N/AN/AN/AN/A-31.6%N/AN/AFeb 12, 2019$8.01M
    Sep 30, 2018$0.02N/AN/AN/AN/A+100.0%N/AN/ANov 13, 2018$7.28M
    Jun 30, 2018$0.13$0.07N/A+85.71%Beat+18.2%N/AN/ASep 25, 2018$7.87M
    Mar 31, 2018$0.04$0.07N/A-42.86%Miss-50.0%N/AN/AMay 8, 2018$7.17M
    Dec 31, 2017$0.06$0.03N/A+95.00%Beat+17.0%N/AN/AFeb 13, 2018$6.96M
    Sep 30, 2017$0.01$0.03N/A-66.67%Miss-50.0%N/AN/ANov 7, 2017$6.30M
    Jun 30, 2017$0.11N/AN/AN/AN/A+175.0%N/AN/ASep 5, 2017$7.27M
    Mar 31, 2017$0.08N/AN/AN/AN/A+33.3%N/AN/AMay 15, 2017$6.67M
    Dec 31, 2016$0.05$0.03N/A+66.67%Beat-50.0%N/AN/AFeb 7, 2017$6.37M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jun 30, 2026 was $1.31, up 55.6% from the year before. It was $0.26 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jun 30, 2026$1.31+55.6%
    Jun 30, 2025$0.84+44.8%
    Jun 30, 2024$0.58+61.1%
    Jun 30, 2023$0.36+38.5%
    Jun 30, 2022$0.26N/A
    Jun 30, 2021$0.26-44.7%
    Jun 30, 2020$0.47+104.3%
    Jun 30, 2019$0.23N/A
    Jun 30, 2018$0.24N/A
    Jun 30, 2017$0.26N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,200 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20263,1586
    2026Q2Jun 30, 20263,8916
    2026Q1Mar 31, 20264,0726
    2025Q4Dec 31, 20254,8157
    2025Q3Sep 30, 20253,0626
    2025Q2Jun 30, 20252,5515
    2025Q1Mar 31, 20254,0055
    2024Q4Dec 31, 20243,3995

    2026Q3 Earnings Call

    Opening remarks

    Mike Cavanaugh Investor Relations Good afternoon, and thank you for joining the Electromed earnings call. Earlier today, Electromed Inc. released financial results for the third quarter of fiscal 2026. The press release is currently available on the company's website at www.smartvest.com. Before we get started, I would like to remind everyone that some of the statements that management will make on this call are considered forward-looking statements, including statements about the company's future operating and financial results and plans. Such statements are subject to risks and uncertainties that could cause actual performance or achievements to be materially different from those projected. Any such statements represent management's expectations as of today's date. You should not place any undue reliance on those forward-looking statements and the company does not undertake any obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Please refer to the company's SEC filings for further guidance on this matter. Joining me on the call today are Jim Cunniff, Electromed's President and Chief Executive Officer; and Brad Nagel, Chief Financial Officer. As on previous calls, Jim will provide operational highlights from the quarter. Brad will then review the financials and we will close with a question-and-answer session. With that, I will now turn the call over to Jim Cunniff, President and Chief Executive Officer of Electromed.

    James Cunniff President and Chief Executive Officer Good afternoon, everyone, and thank you for joining us today. I'm excited to share our third quarter results. Let me start with the headlines. Q3 marks our 14th consecutive quarter of year-over-year revenue and profit growth. We delivered revenue of $18.6 million, representing 18.4% growth compared to the prior year. This performance reflects the strength of our commercial execution and the growing recognition of SmartVest as the leading solution for Airway Clearance. Growth was broad-based across our business. Our flagship Home Care segment grew a robust 19%. Our distributor revenues increased 3% driven by consistent demand from our DME partners. Hospital grew 43% over prior year and rebounded after a slow second quarter. This diversified growth demonstrates the strength of our market position and the effectiveness of our multichannel strategy. Even more impressive is our record bottom line performance. Operating income increased to $3.8 million in the third quarter, a 76% increase versus prior year. Diluted earnings per share came in at $0.35, up 67% versus the prior year. From a balance sheet perspective, we maintained a strong cash position of $17 million. As you may recall, our Board approved a $10 million stock repurchase authorization in the first quarter, reflecting our confidence that Electromed represents a sound investment; yet we slowed repurchasing activity in Q3 as we assess the recent macro market dynamics.

    Frequently Asked Questions About ELMD

    When is Electromed's next earnings date?

    Electromed's next earnings report is expected for Feb 8, 2027.

    Did ELMD beat earnings estimates last quarter?

    Yes. Electromed reported EPS of $0.32 for the quarter ended Sep 30, 2026, above the $0.26 estimate, a 23.08% surprise.

    What EPS do analysts expect from ELMD next quarter?

    The consensus EPS estimate for Electromed for the quarter ending Dec 31, 2026 is $0.39 from 2 analysts, with estimates from $0.36 to $0.41.

    How often does ELMD beat earnings estimates?

    Electromed beat the EPS estimate in each of the last 12 quarters, with an average surprise of +64.26%.